Etropal AD (XBUL:ETR) ROCE % : 0.00% (As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Etropal AD ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Etropal AD's annualized ROCE % for the quarter that ended in Dec. 2023 was 0.00%.

Etropal AD ROCE % Historical Data

The historical data trend for Etropal AD's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Etropal AD ROCE % Chart

Etropal AD Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

4.96

4.57

-37.69

-4.64

2.32

Etropal AD Quarterly Data
	Dec10	Dec11	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Dec23
ROCE %	Get a 7-Day Free Trial														-14.53	-3.61	1.26	-1.29	-

Etropal AD ROCE % Calculation

Etropal AD's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	0.232	/	( ( (17.95 - 7.516)	+	(18.562 - 9.003) )	/ 2 )
	=	0.232	/	( (10.434	+	9.559)	/ 2 )
	=	0.232	/	9.9965
	=	2.32 %

Etropal AD's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Dec. 2022 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Dec. 2022 )		(Q: Dec. 2023 )
	=	0	/	( ( (17.95 - 7.516)	+	(18.562 - 9.003) )	/ 2 )
	=	0	/	( ( 10.434	+	9.559 )	/ 2 )
	=	0	/	9.9965
	=	0.00 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Etropal AD (XBUL:ETR) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Etropal AD ROCE % Related Terms

Thank you for viewing the detailed overview of Etropal AD's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Etropal AD Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Etropal AD (XBUL:ETR) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

191 Rusky Boulevard, Etropole, Sofia, BGR, 2180

Website

http://www.etropal.eu

Etropal AD is engaged in the business of manufacturing medical accessories. The product portfolio includes fistula needles, blood taking sets, transfusion and infusion sets, catheters and tubes, urine collecting bags, colostomy bags, among others. The company also produces hip - joint endoprosthesis and instruments of implantation.